1d
MedPage Today on MSNPembrolizumab-Olaparib Boosts PFS in Non-BRCA Ovarian CancerA first-line regimen involving pembrolizumab (Keytruda) and olaparib (Lynparza) significantly reduced the risk of disease ...
4d
Verywell Health on MSNThe 3 Types of Ovarian Cancer and How They Are DifferentMedically reviewed by Renita White, MD Cancer that develops in the ovaries (the egg-producing reproductive organs) is ...
Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...
A clinician nudge for referral to a gynecologic oncologist at the time of suspected ovarian cancer diagnosis improved referral rates by 20 percentage points, according to study results.Nearly a third ...
Ovarian cancer is the sixth most common form of cancer in women in the UK - and four symptoms could be signs. One symptom can ...
Ovarian cancer is often diagnosed late because its symptoms resemble those of less serious conditions. As a result, only 20% ...
1d
Clinical Trials Arena on MSNAbbVie reports final analysis from Phase III trial of Elahere for ovarian cancerAbbVie has reported analysis from a Phase III trial that assessed Elahere against chemotherapy for platinum-resistant ovarian ...
Pitt research uncovers new insights into ovarian cancer origins, shedding light on potential early detection and treatment ...
An ovarian cancer campaigner, fundraiser and survivor from Norfolk who has taken her story to parliament, is raising awareness of ovarian cancer and the importance of getting checked if something ...
Ovarian cancer may present a threat to the fallopian tubes and peritoneum. Oncologists Dr. Sai Lakshmi Daayana and Dr. Ajay ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results